TEAD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.000600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.111000E-01
Normal-vs-Stage2
6.941000E-01
Normal-vs-Stage3
5.076800E-01
Normal-vs-Stage4
4.981200E-01
Stage1-vs-Stage2
6.566200E-01
Stage1-vs-Stage3
2.547800E-02
Stage1-vs-Stage4
8.094400E-01
Stage2-vs-Stage3
2.001000E-01
Stage2-vs-Stage4
5.770200E-01
Stage3-vs-Stage4
1.055020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.102000E-01
Normal-vs-AfricanAmerican
6.647400E-01
Normal-vs-Asian
9.789200E-01
Caucasian-vs-AfricanAmerican
6.933000E-01
Caucasian-vs-Asian
6.901800E-01
AfricanAmerican-vs-Asian
6.304600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.740800E-01
Normal-vs-Female
7.425000E-01
Male-vs-Female
4.928600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.441600E-01
Normal-vs-Age(41-60Yrs)
3.612600E-01
Normal-vs-Age(61-80Yrs)
8.586200E-01
Normal-vs-Age(81-100Yrs)
7.823000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.213200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.159600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.387800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.259970E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.579600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.988400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.888000E-01
Normal-vs-Daily Drinker
7.970400E-01
Normal-vs-Weekly Drinker
6.813000E-01
Normal-vs-Occasional Drinker
4.981400E-01
Normal-vs-Social Drinker
4.027000E-01
Non Drinker-vs-Daily Drinker
9.377600E-01
Non Drinker-vs-Weekly Drinker
2.292800E-01
Non Drinker-vs-Occasional Drinker
5.386100E-02
Non Drinker-vs-Social Drinker
3.946200E-02
Daily Drinker-vs-Weekly Drinker
1.890150E-01
Daily Drinker-vs-Occasional Drinker
5.137700E-02
Daily Drinker-vs-Social Drinker
4.160100E-02
Weekly Drinker-vs-Occasional Drinker
6.769000E-01
Weekly Drinker-vs-Social Drinker
3.842600E-01
Occasional Drinker-vs-Social Drinker
5.688600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.149400E-01
Normal-vs-Grade 2
9.501800E-02
Normal-vs-Grade 3
1.026830E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.188200E-01
Grade 1-vs-Grade 3
2.177400E-01
Grade 1-vs-Grade 4
3.149400E-01
Grade 2-vs-Grade 3
7.764600E-01
Grade 2-vs-Grade 4
9.501800E-02
Grade 3-vs-Grade 4
1.026830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.891200E-01
Normal-vs-NonDiabetic
7.380400E-01
Diabetic-vs-NonDiabetic
6.041200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.896400E-01
Normal-vs-NoPancreatitis
7.771000E-01
Pancreatitis-vs-NoPancreatitis
6.405600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.551000E-01
Normal-vs-N1
6.811800E-01
N0-vs-N1
9.103200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.054200E-01
Normal-vs-TP53-NonMutant
7.508400E-01
TP53-Mutant-vs-TP53-NonMutant
4.566200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
